Why the study?
Does DNA ploidy status correlate with patient survival in patients with synovial sarcoma?
Does DNA ploidy status correlate with patient survival in patients with synovial sarcoma?
DNA ploidy analysis serves as a significant objective prognostic marker for survival in patients with synovial sarcoma.
Answers are grounded in this paper and cite their sources.
Ploidy status may refine prognostication in synovial sarcoma; hypothesis-generating and requires prospective validation before practice change.
The relationship between DNA content, clinicopathologic findings, and patient survival in synovial sarcoma was investigated. Patient age at diagnosis (P less than 0.001), tumor size (P less than 0.001), and ploidy status (P less than 0.003) correlated significantly with patient survival. A marginally significant correlation between mitotic count and patient survival was also observed (P = 0.04). Histologic subtypes (monophasic versus biphasic), mitotic count, and S-phase by flow cytometry had no significant influence on the clinical outcome of patients with synovial sarcoma in this study. The authors conclude that DNA ploidy analysis is a significant objective probe in the prognostication of patients with synovial sarcoma.
No takes yet. Share an insight, caveat, or question.
El-Naggar et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: